Does hydralazine affect heart rate more than metoprolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydralazine Increases Heart Rate While Metoprolol Decreases It

Hydralazine causes a reflex increase in heart rate through sympathetic activation, whereas metoprolol (a beta-blocker) decreases heart rate—these drugs have opposite effects on heart rate. 1, 2, 3

Mechanism of Hydralazine's Effect on Heart Rate

  • Hydralazine causes reflex tachycardia as a compensatory mechanism to its arterial vasodilation, leading to increased sympathetic tone and elevated heart rate 1, 2
  • The FDA label confirms that hydralazine's peripheral vasodilating effect results in increased heart rate, stroke volume, and cardiac output as direct consequences of decreased arterial blood pressure 2
  • In clinical studies, hydralazine increased heart rate by 28% on average in patients with sinus bradycardia, primarily through decreased sinoatrial conduction time 4
  • This chronotropic effect is mediated almost entirely by the autonomic nervous system—when autonomic blockade was achieved, hydralazine's heart rate effect was abolished 4

Mechanism of Metoprolol's Effect on Heart Rate

  • Metoprolol decreases heart rate through beta-adrenergic blockade, slowing atrioventricular conduction and reducing sympathetic drive to the heart 3
  • The FDA label specifically warns that concomitant use of metoprolol with digitalis glycosides increases the risk of bradycardia due to additive effects on slowing heart rate 3
  • Beta-blockers like metoprolol are used specifically to counteract the reflex tachycardia caused by vasodilators like hydralazine 1

Clinical Implications and Combination Therapy

  • The American College of Cardiology recommends using hydralazine with background beta-blocker therapy specifically because hydralazine increases sympathetic tone and causes reflex tachycardia 1
  • When hydralazine is combined with metoprolol, the beta-blocker minimizes the reflex tachycardia that would otherwise occur 1
  • The FDA drug interaction data confirms that concomitant administration of hydralazine may inhibit presystemic metabolism of metoprolol, leading to increased metoprolol concentrations and enhanced heart rate reduction 3
  • In heart failure management, the combination of hydralazine/isosorbide dinitrate is always given with background beta-blocker therapy to prevent excessive tachycardia 5, 1

Quantitative Effects

  • Hydralazine increased heart rate by approximately 17-28% in clinical studies of hypertensive patients 4, 6
  • In one study, heart rate rose from 61.9 to 68.6 beats per minute after intravenous hydralazine administration 7
  • Metoprolol's target dosing aims to achieve heart rate control, with typical reductions bringing heart rate into the 50-60 beats per minute range when combined with other agents like ivabradine 5

Critical Caveat

  • Hydralazine should never be used as monotherapy in conditions where tachycardia could be harmful (such as myocardial infarction or heart failure), as the reflex tachycardia can provoke myocardial ischemia 1, 8
  • The combination of these drugs requires careful monitoring, as the interaction can lead to unpredictable blood pressure responses and enhanced bradycardia if metoprolol levels increase 3

References

Guideline

Hydralazine's Effects on Blood Pressure and Heart Rate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemodynamic effects of oxdralazine and hydralazine in hypertension.

Clinical pharmacology and therapeutics, 1980

Guideline

Hydralazine Use in Heart Failure with Reduced Ejection Fraction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.